Phase Ib Study of CBP-1019 in Combination With FOLFOX +/- Bevacizumab, Pembrolizumab, or Enzalutamide for Metastatic TRPV6-overexpressing Solid Tumors of Epithelial Origin
Clinical trial NCT06576037 · RECRUITING
Trial details
- NCT number
- NCT06576037
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-31
- Primary completion
- 2027-06-01
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.